Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
TKTL1 Is Activated by Promoter Hypomethylation and Contributes to Head and Neck Squamous Cell Carcinoma Carcinogenesis through Increased Aerobic Glycolysis and HIF1α Stabilization
2010
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
2009 StandoutScience
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
2018 StandoutScienceNobel
WGCNA: an R package for weighted correlation network analysis
2008 Standout
MicroRNA-214 Suppresses Growth and Invasiveness of Cervical Cancer Cells by Targeting UDP-N-acetyl-α-d-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase 7
2012
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
2001
Hallmarks of Cancer: The Next Generation
2011 Standout
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Age-related mutations associated with clonal hematopoietic expansion and malignancies
2014
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
2001
Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B‐cell lymphoma
2002
Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma
1999
The Clinical Significance of CD10 Antigen Expression in Diffuse Large B-Cell Lymphoma
2001
Karyotyping human chromosomes by combinatorial multi-fluor FISH
1996
Mechanisms of chromosomal translocations in B cell lymphomas
2001
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
2011
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection
2007
Cancer Metastasis: Building a Framework
2006 Standout
Clinicopathologic Analysis of CD10+ and CD10– Diffuse Large B-Cell Lymphoma
2001
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Genetic instabilities in human cancers
1998 StandoutNature
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
1998 StandoutNatureNobel
Lineage dependency and lineage-survival oncogenes in human cancer
2006
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
2004 StandoutNobel
The changing landscape of atherosclerosis
2021 StandoutNature
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
1999
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
Novel Recurrent Genetic Imbalances in Human Hepatocellular Carcinoma Cell Lines Identified by Comparative Genomic Hybridization
1999
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Solution structure of the nonmethyl‐CpG‐binding CXXC domain of the leukaemia‐associated MLL histone methyltransferase
2006
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
2008 StandoutNature
Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer
2013
Immunohistochemical Expression Patterns of Germinal Center and Activation B-cell Markers Correlate With Prognosis in Diffuse Large B-cell Lymphoma
2004
The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2
2006
Genomic insights into head and neck cancer
2016
Cancer vaccines: between the idea and the reality
2003
The natural history of cervical HPV infection: unresolved issues
2006
Primary vs. secondary neoplasia-associated chromosomal abnormalities—balanced rearrangements vs. genomic imbalances?
1996
Analysis of the coding genome of diffuse large B-cell lymphoma
2011
Cancer immunotherapy comes of age
2011 StandoutNature
Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas
2005 StandoutNobel
The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition
2007
Fluorescence in situ hybridization: A brief review
1996
The molecular landscape of head and neck cancer
2018 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
Mechanism and relevance of ploidy in neuroblastoma
2000
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
2010 StandoutNature
Genetic parameters of neuroblastomas
2002
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions
2014
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response
2004
The role of the bcl-2/ced-9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
1997
The occurrence and significance of V gene mutations in B cell—Derived human malignancy
2001
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Rearrangements of Bcl-1, Bcl-2, Bcl-6, and C-Myc in Diffuse Large B-Cell Lymphomas
2001
CD10 and BCL-6 Expression in Paraffin Sections of Normal Lymphoid Tissue and B-Cell Lymphomas
2000
Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
2000
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
New Approaches to Immunotherapy for HPV Associated Cancers
2011
The gastric marginal zone B-cell lymphoma of MALT type
2000
Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
2001
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.
2003
An empirical Bayes approach to inferring large-scale gene association networks
2004
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6
2000
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals
2022 StandoutScienceNobel
A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.
2000
Engineering Orthogonal Polypeptide GalNAc-Transferase and UDP-Sugar Pairs
2019 StandoutNobel
Nonimmunoglobulin (non-Ig)/BCL6gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6
2000
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Cancer Genome Landscapes
2013 StandoutScience
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
The gastric marginal zone B-cell lymphoma of MALT type
2000
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
1998 StandoutScience
Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma
2001
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma
2002
Works of Ed Schuuring being referenced
Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome
2008
CD44 Expression Predicts Local Recurrence after Radiotherapy in Larynx Cancer
2010
Retroviral insertional mutagenesis in murine mammary cancer
1985
Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors
2013
Detection of cervical neoplasia by DNA methylation analysis in cervico-vaginal lavages, a feasibility study
2010
Prognostic Cell Biological Markers in Cervical Cancer Patients Primarily Treated With (Chemo)radiation: A Systematic Review
2011
Detection of three common translocation breakpoints in non‐Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin‐embedded tissue sections
2002
Multiple and sensitive fluorescence in situ hybridization with rhodamine-, fluorescein-, and coumarin-labeled DNAs
1993
Overexpression of Intrinsic Hypoxia Markers HIF1α and CA-IX Predict for Local Recurrence in Stage T1-T2 Glottic Laryngeal Carcinoma Treated With Radiotherapy
2008
β2‐microglobulin aberrations in diffuse large B‐cell lymphoma of the testis and the central nervous system
2002
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
1998
Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4
2001
The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes-a review
1995
Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma
1999
Cytokine Profile of Cervical Cancer Cells
2001
Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis
1997
LAF4, an AF4‐related gene, is fused to MLL in infant acute lymphoblastic leukemia
2002
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia
2012
Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I–II trial
1999
Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13
2004
Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites
2000
Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals
1995
Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia
2007
2013
V(D)J recombinase-mediated transposition of the BCL2gene to the IGH locus in follicular lymphoma
2000
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma
1998
Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification.
1996